We’ve put some small files called cookies on your device to make our site work.
We’d also like to use analytics cookies. These send information about how our site is used to a service called Google Analytics. We use this information to improve our site.
Let us know if this is OK. We’ll use a cookie to save your choice. You can read more about our cookies before you choose.
Change my preferences
I'm OK with analytics cookies
Letter from Dr Keith Ridge to support prescribing decisions, NICE guideline NG144 on Cannabis-Based Medicinal Products (CBMPs) which was published in November 2019.